← Leaderboards
James Evans
Phenovista Biosciences, Llc
$674,667
Attributed
$1,824,150
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $883.9K · FY2017–21$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,824,150 · 3
By mechanism
R44$1,424,450 · 1
R43$399,700 · 2
Top collaborators
- Anthony Weber Essex4 shared
- Alysson R. Muotri2 shared
Most similar at Phenovista Biosciences, Llc
Same institution · by research overlap
- Anthony Weber Essex$674,667
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposDrug DiscoveryIn VivoPhenotypeTechnologyBiologyPerformanceNext GenerationPharmaceutical PreparationsCellsS Disease ModelSmall Business Innovation Research GrantS DiseaseBrainCostIn VitroDisease ModelNeuronsCell TypeAffectAreaFamilial Alzheimer DiseaseClientCharacteristics
Grant awards (4)
iPSC-Derived Neuronal Models of Alzheimer's Disease for Phenotypic Drug Screening$634,006
R44 · FY2021 · AG · contact PI
Microglia models for Alzheimer's disease drug screening$249,900
R43 · FY2021 · AG · contact PI
iPSC-Derived Neuronal Models of Alzheimer's Disease for Phenotypic Drug Screening$790,444
R44 · FY2020 · AG · contact PI
iPSC-Derived Neuronal Models of Alzheimer's Disease for Drug Screening$149,800
R43 · FY2017 · AG · contact PI